Our fully integrated GxP services are driven by your assay requirements and delivered by our veteran scientists – collaboratively, accurately, and on time.
Biomarkers
Immunogenicity
Pharmacokinetics (PK)
Cell-Based Assays
Our team is comprised of recognized experts in effectively navigating complex and evolving opportunities for biotherapeutics innovation.
Biosimilars
Gene Therapy
Antibody Drug Conjugates (ADCs)
Immuno-oncology
Explore the BioAgilytix way of thinking. Visit our Resource Center to learn more about our scientists’ expertise through case studies, blogs, industry articles and other scientific resources.
Quick links to our latest content offerings:
LinkedIn Company Updates
2 Days Agoview on linkedin
Glaucoma affects 70 million people worldwide, but the mechanisms that contribute to the disease aren’t yet fully understood. A recent study suggests that glaucoma could actually be an autoimmune disease. Learn more via Genetic Engineering & Biotechnology News: https://lnkd.in/g7Bn8AY
2 Days Agoview on linkedin
Are you attending IDDST-2018? Join BioAgilytix’s Todd Lester today for his presentation entitled “Recommendations for the Development and Validation of Neutralizing Antibody Assays in Support of Biosimilar Assessment”. The session begins at 3:25pm in the Enterprise Room, 3rd Floor. Details here: https://lnkd.in/eGk5Nxv
3 Days Agoview on linkedin
Introducing new bioanalytical technologies, or improvements to existing technology, in the middle of a project is inherently risky. How do you determine if it is worth the risk? We discuss with Bioanalysis Zone: https://lnkd.in/gyNAiWh
August 15, 2018BioAgilytix Team Q&A: Meet Sarah Rieveschl, Business Development Director at BioAgilytix
August 8, 2018Setting Yourself Up for Success: Advice for Early Career Scientists
August 15, 2018BioAgilytix Named to Inc. Magazine’s Inc. 5000 List of Fastest-Growing Private U.S. Companies for Fifth Time
August 13, 2018BioAgilytix Recognized by Triangle Business Journal as a 2018 Leader in Diversity
May 9, 2018Evaluating the Immunogenicity of Antibody–drug Conjugates
April 16, 2018Strategies for Development and Validation of Neutralizing Antibody Assays Supporting Biosimilars
Services
Platforms
